Exagen Inc. · NASDAQ:XGN
Aballi John sold 34,294 Exagen Inc. shares (Form 4)
Traded Oct 16, 2026 · Filed Oct 19, 2026
On Oct 16, 2026, Aballi John (Director, President and CEO) sold 34,294 Exagen Inc. shares at US$7.87 for US$270K, leaving 805,540 shares. Filed Oct 19, 2026 (Form 4).
- Sold
- 34,294 shares
- Price
- US$7.87
- Value
- US$270K
- Holding after
- 805,540 shares
- Trading plan
- No
- Role
- Director, President and CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 16, 2026 | Common Stock | Sale | 34,294 | US$7.87 | 805,540 | Direct |
Source
Download original · View original at SEC